Tokyo - Delayed Quote JPY

Human Metabolome Technologies, Inc. (6090.T)

695.00
-1.00
(-0.14%)
At close: 3:30:00 PM GMT+9

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in JPY.
NameTitlePayExercisedYear Born
Mr. Yasuhiro Ohata President, CFO & Chairman -- -- 1965
Mr. Masaru Tomita Ph.D. Co-Founder and Member of Technical Advisory Board -- -- --
Dr. Tomoyoshi Soga Ph.D. Co-Founder and Member of Technical Advisory Board -- -- --
Mr. Kenjiro Kami COO, GM of Business Management Division & Director -- -- 1975
Jun Nagashima Chief Information Officer & Executive Officer -- -- 1974
Atsushi Nagashima Executive Officer & GM of Information System Department -- -- --
Naotaka Kametani Executive Officer & Chief Alliance Officer -- -- 1972

Human Metabolome Technologies, Inc.

246-2 Mizukami Kakuganji
Tsuruoka, 997-0052
Japan
81 3 3551 2180 https://www.humanmetabolome.com
Sector: 
Healthcare
Full Time Employees: 
58

Description

Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan. The company provides metabolome analysis services; and global profiling, targeted assays, flux analysis, and lipidomics services. It also develops biomarkers, such as Phosphorylethanolamine, a biomarker for major depressive disorder and measured in blood plasma. The company offers solutions for cancer metabolism, metabolic flux analysis, infectious diseases, basic science, preclinical and clinical, food and nutrition, and microbiome applications. It has a collaboration with the Institute for Advanced Biosciences and Keio University for the development of metabolome analysis technology. The company was incorporated in 2003 and is based in Tsuruoka, Japan.

Corporate Governance

Human Metabolome Technologies, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 14, 2025 at 6:00 AM UTC

Human Metabolome Technologies, Inc. Earnings Date

June 27, 2025 at 12:00 AM UTC

Ex-Dividend Date

Recent Events